- Home
- IPHA vs NEOV Comparison
IPHA vs NEOV Comparison
Compare IPHA & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- NEOV
- Stock Information
- Founded
- IPHA 1999
- NEOV 2018
- Country
- IPHA France
- NEOV United States
- Employees
- IPHA N/A
- NEOV N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- NEOV Industrial Machinery/Components
- Sector
- IPHA Health Care
- NEOV Miscellaneous
- Exchange
- IPHA Nasdaq
- NEOV Nasdaq
- Market Cap
- IPHA 160.1M
- NEOV 148.1M
- IPO Year
- IPHA 2019
- NEOV N/A
- Fundamental
- Price
- IPHA $2.18
- NEOV $4.22
- Analyst Decision
- IPHA Hold
- NEOV Hold
- Analyst Count
- IPHA 2
- NEOV 1
- Target Price
- IPHA $2.00
- NEOV N/A
- AVG Volume (30 Days)
- IPHA 12.3K
- NEOV 367.9K
- Earning Date
- IPHA 09-17-2025
- NEOV 11-10-2025
- Dividend Yield
- IPHA N/A
- NEOV N/A
- EPS Growth
- IPHA N/A
- NEOV N/A
- EPS
- IPHA N/A
- NEOV N/A
- Revenue
- IPHA $14,839,695.00
- NEOV $8,426,835.00
- Revenue This Year
- IPHA $50.89
- NEOV $91.25
- Revenue Next Year
- IPHA N/A
- NEOV $30.38
- P/E Ratio
- IPHA N/A
- NEOV N/A
- Revenue Growth
- IPHA N/A
- NEOV 218.59
- 52 Week Low
- IPHA $1.29
- NEOV $1.80
- 52 Week High
- IPHA $3.51
- NEOV $6.19
- Technical
- Relative Strength Index (RSI)
- IPHA 60.94
- NEOV 41.55
- Support Level
- IPHA $2.07
- NEOV $3.83
- Resistance Level
- IPHA $2.28
- NEOV $4.49
- Average True Range (ATR)
- IPHA 0.09
- NEOV 0.52
- MACD
- IPHA 0.01
- NEOV -0.15
- Stochastic Oscillator
- IPHA 69.70
- NEOV 17.16
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.